Search research articles
Contact Us
Filters
Showing results (111-120 of 116) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 116 results.
Oncogene
|
February 16, 2010
ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients
T Müller, U Stein, A Poletti, et al.
Cancer Chemotherapy and Pharmacology
|
April 1, 2014
Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma
A Thiery-Vuillemin, G Mouillet, T Nguyen Tan Hon, et al.
Oncogene
|
December 22, 2015
SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival
F Schmid, Q Wang, M R Huska, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON Study
P Barthelemy, A Thiery-Vuillemin, T Lebret, et al.
Oncogene
|
January 29, 2014
A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4
M T Hansen, B Forst, N Cremers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies
U-P Rohr, P Herrmann, K Ilm, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 116) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 116 results.
Oncogene
|
February 16, 2010
ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients
T Müller, U Stein, A Poletti, et al.
Cancer Chemotherapy and Pharmacology
|
April 1, 2014
Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma
A Thiery-Vuillemin, G Mouillet, T Nguyen Tan Hon, et al.
Oncogene
|
December 22, 2015
SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival
F Schmid, Q Wang, M R Huska, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON Study
P Barthelemy, A Thiery-Vuillemin, T Lebret, et al.
Oncogene
|
January 29, 2014
A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4
M T Hansen, B Forst, N Cremers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies
U-P Rohr, P Herrmann, K Ilm, et al.
Page
of 12